CN112961863A - Porcine IgA class-switched transcript alpha long and short sequences - Google Patents
Porcine IgA class-switched transcript alpha long and short sequences Download PDFInfo
- Publication number
- CN112961863A CN112961863A CN202110206756.1A CN202110206756A CN112961863A CN 112961863 A CN112961863 A CN 112961863A CN 202110206756 A CN202110206756 A CN 202110206756A CN 112961863 A CN112961863 A CN 112961863A
- Authority
- CN
- China
- Prior art keywords
- alpha
- seq
- pig
- iga
- transcript
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses pig IgA+B-cell class switch recombinant marker-transcript α long, short sequence: IDNo.9 and SEQ ID No.10, and porcine IgA+Detection method of B cell class conversion recombination. The detection method comprises the steps of extracting RNA from a lymphatic tissue sample of a pig to be detected, carrying out reverse transcription on the RNA, taking the obtained cDNA as a template to be detected, carrying out amplification by using the primer sequences SEQ ID No.3 and SEQ ID No.4 disclosed by the invention, and determining IgA of the pig to be detected according to the fact that whether a specific band appears in a nucleic acid electrophoresis chart of an amplification product or not and the molecular weight standard of the DNA+B cell class switch recombination events. The invention can be applied to the preparation of reagents for evaluating the pig IgA mucosal immune activation condition.
Description
Technical Field
The invention relates to pig IgA+Marker sequences for B cell class switch recombination, and porcine IgA+Detection method of B cell class conversion recombination.
Background
IgA+The three key products of B cell class conversion recombination refer to transcription products generated by B cells in the process of IgA class conversion recombination: α germ-line transcripts (α 0GLT), i.e., I α 1C α 2; IgA class switched transcripts α (PST α), i.e., I μ C α and α loop transcripts (α circle transcripts, α CT), i.e., I α C μ.
Mucosal immune responses, particularly secretory immunoglobulin a (siga), are critical for fighting pathogenic infections and maintaining the health and the micro-ecological balance of the body. The intestinal mucosa is the largest mucosal tissue of human and animal bodies, and the Peyer's Patches (PP knots) of the intestinal tract is formed by orderly gathering small intestinal mucosa lymphoid tissues and is the main part for intestinal mucosa immunity generation and IgA antibody generation. Mesenteric Lymph Nodes (MLNs) are also important immune tissues of the gut and play an important role in maintaining the gut immune response.
After B cells are stimulated by antigen, two important processes of antibody Class Switching Recombination (CSR) and affinity maturation (SHM) are needed to form high-affinity IgA+B cells. During IgA class switch recombination (IgA CSR), exons of the heavy chain constant region encoding immunoglobulin (Ig) are converted from C μ encoding IgM to C α encoding IgA, while the variable region of the bound antigen remains constant. IgA antibody class switching recombination begins with the production of an inducible non-coding α germline transcript (. alpha.0 GLT) -lalpha 1 C.alpha.2, under the action of activation-induced cytidine deaminase (AICDA, AID) highly expressed in cells, the DNAs of the S.mu.and S.alpha.3 switching regions of the genome are each double-stranded cleaved and end-cleaved by repair and ligation, leaving the original DNA sequence spaced from S.mu.and S.alpha.4 excised to form a loop product, which, due to its overlying promoter (. alpha.5), transiently encodes the α 6 loop transcript (. alpha.CT) -lalpha.C.mu before degradation; the two distal transition sequences are joined to form the final transition recombination product, which encodes the IgA class transition transcript α (PST α) -I μ C α, causing the B cell to change from initially expressed IgM to IgA. In this process, α GLT, PST α, and in particular α CT are the most direct evidence of class switching recombination in vitro and in vivo.
At present, mucosal immunity is studied in many miceAs a model, the three transcription products are mature and are applied to in vivo and in vitro evaluation of IgA+B cell class switching recombination. However, mucosal immunity in pigs was rarely studied, porcine IgA+The research of B cell class conversion recombination is still blank at present, and the shortage of research tools greatly hinders the development of porcine mucosal immunology. Pigs are not only an important economic animal; can also be used as a big animal model to make up the defects of the traditional experimental animal models such as mice, rats, rabbits and other small animals, and is applied to scientific research. Development and perfection of research tools and research methods are important for development and progress of porcine mucosal immunology. Detection of porcine alpha GLT, PST alpha, especially alpha CT as IgA in vitro and in vivo+The most direct evidence of B cell class conversion recombination has great significance for evaluating the mucosal immune response of the pigs. The method can be used as pathogen infection, vaccine immunity, and various factors and adjuvants for treating IgA+Evaluation indexes of B cell differentiation and mucosal immune response activation. Provides basis for discovering and selecting effective mucosal immune adjuvant, vaccine and immune strategy.
Object of the Invention
The invention provides a marker capable of being used for detecting the activation condition of pig IgA mucosal immune response, a detection method and possible application.
The pig IgA mucosal immune response activation condition markers are as follows:
1) the gene sequence of the porcine alpha embryonic line transcript alpha GLT is SEQ ID No. 8;
2) the pig IgA class converted transcript alpha short sequence PST alpha-1 has the gene sequence of SEQ ID No. 9;
3) the pig IgA class converted transcript alpha long sequence PST alpha-2 has the gene sequence of SEQ ID No. 10;
4) the gene sequence of the porcine alpha loop transcript alpha CT is SEQ ID No. 11.
The pig IgA class conversion recombination detection method of the invention is to extract RNA from a lymphoid tissue sample of a pig to be detected and carry out reverse transcription, then the obtained cDNA is used as a template to be detected, and primer sequences SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4, SEQ ID No.5, SEQ ID No.6 and SEQ ID No.7 are used for carrying out amplificationAmplifying, and determining IgA of the pig to be detected according to the DNA molecular weight standard of the specific band in the nucleic acid electrophoresis image of the amplified product+B cell class switch recombination events.
The primer sequence is as follows: SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4, SEQ ID No.5, SEQ ID No.6 or/and SEQ ID No.7 can be used for the detection of porcine IgA class switch recombination.
Any marker sequence can be applied to preparation of a reagent for detecting pig IgA mucosal immune activation.
Any one of the primer sequences SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4, SEQ ID No.5, SEQ ID No.6 and SEQ ID No.7 or any combination thereof disclosed by the invention can be applied to preparation of a reagent for evaluating the pig IgA mucosal immune activation condition.
Drawings
FIG. 1: pig peyer's patches alpha GLT, PST alpha and alpha CT amplification results (electropherogram);
FIG. 2: porcine mesenteric lymph node alpha GLT, PST alpha and alpha CT amplification results (electropherogram);
FIG. 3: the structure diagrams of porcine alpha GLT, PST alpha and alpha CT sequences;
FIG. 4: repeating detection results (electrophorograms) in batches by using porcine alpha GLT, PST alpha and alpha CT amplification methods;
FIG. 5: porcine alpha GLT, PST alpha and alpha CT amplification methods were run-to-run to repeat the test results (electropherograms).
Detailed Description
The invention is further illustrated by the following description of specific examples and the accompanying drawings
The PCR detection method of pig IgA class conversion recombination is that RNA is extracted from lymph tissue sample of pig to be detected through Trizol method or RNA extracting kit, 2 mug RNA is added into 1 mug reverse transcription primer oligo (dT) to incubate in 65 deg.C water bath for 5 min, the mixture is taken out and stood in ice bath for 2 min, then the mixture is added into a premixed system containing reverse transcriptase, dNTP, RNase inhibitor and reaction buffer solution, reverse transcription is carried out in 42 deg.C water bath for 1 h, and heating is carried out at 70 deg.C for 5 min to inactivate the reverse transcriptase. The obtained cDNA is used as a template to be detected, the primer and the reaction condition provided by the patent are used for amplification, the amplification product is subjected to nucleic acid electrophoresis by agarose gel with the concentration of 1.5 percent, and the expression conditions of alpha GLT, PST alpha and alpha CT in a pig sample to be detected are determined according to the fact whether a specific band is present in a nucleic acid electrophoresis image of the amplification product or not by contrasting the DNA molecular weight standard.
Example 1. design and Synthesis of alpha embryonic transcripts, alpha circular transcripts and post-conversion transcripts alpha PCR primers.
The promoter regions I mu and I alpha before the heavy chain constant regions (C mu and C alpha) encoding IgM and IgA on the genome were predicted using the known porcine antibody heavy chain region genomic sequences (accession numbers AB699686 and AB699687) and published relevant literature. And designing primers PF on the I mu prediction sequence, GF and CF1 on the I alpha prediction sequence, CR1 and CR2 on the C mu sequence, and GR and PF on the C alpha sequence. The designed primer is synthesized by Xian Ongkexi Biotechnology Limited liability company. The seven primer sequences and the corresponding sequence numbers are respectively as follows:
example 2 determination of reaction conditions
Firstly, setting different annealing temperatures (54-65 ℃) for amplification, screening the optimal annealing temperatures for alpha GLT and PST alpha amplification, and finally determining the optimal annealing temperatures of the alpha GLT and the PST alpha to be 58-61 ℃ and 61-64 ℃ respectively through optimized screening.
For alpha CT, different annealing temperatures (54-58 ℃) are set for first round amplification, products of the first round are used as templates, different annealing temperatures (60-65 ℃) are set for second round PCR amplification, and the optimal annealing temperatures of two rounds of PCR are screened. The optimal annealing temperatures of the first and second PCR rounds are finally determined to be 54-56 ℃ and 58-61 ℃ respectively through optimization screening.
The results of amplifying α GLT, PST α and α CT in PP and mesenteric lymph nodes at the optimal annealing temperature are shown in fig. 1 and fig. 2, respectively.
Example 3 sequencing of PCR amplification products.
mu.L of the PCR product was mixed with 1. mu. L p-LB-Simple vector, and ligated with T4 DNA ligase and ligation buffer at room temperature for 5 minutes. The mixture after reaction is transformed into DH5 alpha competent cells, positive clones are selected, recombinant plasmids are extracted and sent to the Xian engine science and technology Limited liability company for sequencing. The result shows that the length of the alpha GLT product is 242bp, wherein the alpha GLT product contains 111bp of the I alpha region and 131bp of the C alpha region; the PST alpha has two products, namely 251bp and 515bp respectively, wherein the two products respectively contain 146bp and 410bp of I mu region and 105bp of C alpha region; the length of the alpha CT product is 359bp, and the alpha CT product contains 271bp of the I alpha region and 88bp of the C mu region. The structure of the three products is schematically shown in FIG. 3, and the sequencing results are as follows:
alpha germ line transcripts (alpha GLT), i.e., I α C α.
SEQ ID NO.8:
ACTCCAGCTCCTATGCAGCGGCTGGGCAGATGGACCTGCGGTGTGGGGCCACAAGGCCCGAGAGGCCTGGGCCTCTCCCAGCCACCGTGGACCCTCTGGCAGCTTGAGCAGTGTCTGAAACCAGCCCCAAAATCTTCCCACTGACTCTGGGGAGCAGCGAGCCTGCCGGATATGTGGTCATCGCCTGCCTGGTCCGGGACTTCTTCCCGTCAGAGCCCCTGACAGTAACCTGGAGCCCTAGT。
The IgA class switched transcript α short sequence (Post-switchtranscripts α, PST α), i.e., I μ C α -1.
SEQ ID NO.9:
GCACGATTTTCAGTTGGCCCGCTTCCCCTCGTGATTAGGACAGACGCGGGCACTCTGGCCCAGCCGTCTTGGCTCAGTATCTGCAGGCGTCCGTCTCGGGACGGAGCTCAGGGGAAGAGCGTGACTCCAGTTGAACGTGATAGTCGTGTCTGAAACCAGCCCCAAAATCTTCCCACTGACTCTGGGGAGCAGCGAGCCTGCCGGATATGTGGTCATCGCCTGCCTGGTCCGGGACTTCTTCCCGTCAGAGC。
The IgA class switched transcripts are alpha long sequences (Post-switchtransports alpha, PST alpha-2), i.e., I.mu.Calpha.
SEQ ID NO.10:
GCACGATTTTCAGTTGGCCCGCTTCCCCTCGTGATTAGGACAGACGCGGGCACTCTGGCCCAGCCGTCTTGGCTCAGTATCTGCAGGCGTCCGTCTCGGGACGGAGCTCAGGGGAAGAGCGTGACTCCAGTTGAACGTGATAGTCGGTGCGTTGAGAGGAGACCCAGTCGGGTGTCGAGTCAGAAGGGGCCCGGGGCCCGAGGCCCTGGGCAGGACGGCCCGTGCCCTGCATCACGGGCCCAGCGTCCTAGAGGCAGGACTCTGGTGGAGAGTGTGAGGGTGCCTGGGGCCCCTCCGGAGCTGGGGCCGTGCGGTGCAGGTTGGGCTCTCGGCGCGGTGTTGGCTGTTTCTGCGGGATTTGGAGGAATTCTTCCAGTGATGGGAGTCGCCAGTGACCGGGCACCAGGCTGTGTCTGAAACCAGCCCCAAAATCTTCCCACTGACTCTGGGGAGCAGCGAGCCTGCCGGATATGTGGTCATCGCCTGCCTGGTCCGGGACTTCTTCCCGTCAGAGC。
α circular transcripts (α CT), i.e. I α C μ.
SEQ ID No.11:
ACTCCAGCTCCTATGCAGCGGCTGGGCAGATGGACCTGCGGTGTGGGGCCACAAGGCCCGAGAGGCCTGGGCCTCTCCCAGCCACCGTGGACCCTCTGGCAGCTTGAGCAGGTGGGTCCCAGAGGCTGCTCAGGCCTCAGCTCCTGCACAGCCAGGCCACACCGGGGCCTCCTGGGCTGGAAGCATGGAAGGAAGGCAGGTACCAAAACAAGGAGGAGGAGAAGGAGGAAGGAGGGGCCCTCTAGCCCCGAGGACCGAGGGCAGGATGAACCCAGAACATCCAGGACTTCCCGTCCGTCCTGAGAGGCGGCAAGTACTTGGCCTCCTCCCGGGTGCTCCTACCCTCTGTGAGCATCCCC。
Example 4 repeatability verification
Detecting PP knots alpha GLT, PST alpha and alpha CT by using a determined method, and performing repeated detection in batches to obtain a sample for 3 repeated detections, wherein the result is shown in figure 4; the batch-to-batch repeatability test is that the sample is tested in three times, and the result is shown in FIG. 5; the repeatability of the detection method is good.
The method for detecting the pig IgA class conversion marker based on the PCR technology can be used as the pig IgA+Evaluation of B cell differentiation and activation of mucosal immune response. The technology improves the evaluation method of pig IgA mucosal immune response, and has important significance for the development of pig mucosal immunology. In addition, the technology also provides a reliable method for evaluating pathogens and vaccines, particularly mucosal immune vaccines, adjuvants and the like for activating the IgA mucosal immune response of organisms, thereby providing scientific basis for discovering and selecting effective mucosal immune adjuvants, vaccines and immune methods.
Sequence listing
<110> Lanzhou veterinary research institute of Chinese academy of agricultural sciences
<120> porcine IgA class-converted transcript alpha Long and short sequences
<160> 11
<170> SIPOSequenceListing 1.0
<210> 1
<211> 20
<212> DNA
<213> Artificial sequence (GF)
<400> 1
actccagctc ctatgcagcg 20
<210> 2
<211> 21
<212> DNA
<213> Artificial sequence (GR)
<400> 2
actagggctc caggttactg t 21
<210> 3
<211> 20
<212> DNA
<213> Artificial sequence (PF)
<400> 3
gcacgatttt cagttggccc 20
<210> 4
<211> 20
<212> DNA
<213> Artificial sequence (PR)
<400> 4
gctctgacgg gaagaagtcc 20
<210> 5
<211> 18
<212> DNA
<213> Artificial sequence (CF1)
<400> 5
ctgaggccgc accaccag 18
<210> 6
<211> 20
<212> DNA
<213> Artificial sequence (CR1)
<400> 6
agatggacac ggacttggtg 20
<210> 7
<211> 20
<212> DNA
<213> Artificial sequence (CR2)
<400> 7
ggggatgctc acagagggta 20
<210> 8
<211> 242
<212> DNA
<213> alpha embryonic transcripts (alpha GLT)
<400> 8
actccagctc ctatgcagcg gctgggcaga tggacctgcg gtgtggggcc acaaggcccg 60
agaggcctgg gcctctccca gccaccgtgg accctctggc agcttgagca gtgtctgaaa 120
ccagccccaa aatcttccca ctgactctgg ggagcagcga gcctgccgga tatgtggtca 180
tcgcctgcct ggtccgggac ttcttcccgt cagagcccct gacagtaacc tggagcccta 240
gt 242
<210> 9
<211> 251
<212> DNA
<213> transcript α short sequence after IgA class transition (PST α -1)
<400> 9
gcacgatttt cagttggccc gcttcccctc gtgattagga cagacgcggg cactctggcc 60
cagccgtctt ggctcagtat ctgcaggcgt ccgtctcggg acggagctca ggggaagagc 120
gtgactccag ttgaacgtga tagtcgtgtc tgaaaccagc cccaaaatct tcccactgac 180
tctggggagc agcgagcctg ccggatatgt ggtcatcgcc tgcctggtcc gggacttctt 240
cccgtcagag c 251
<210> 10
<211> 515
<212> DNA
<213> transcript alpha Long sequence after IgA class transition (PST alpha-2)
<400> 10
gcacgatttt cagttggccc gcttcccctc gtgattagga cagacgcggg cactctggcc 60
cagccgtctt ggctcagtat ctgcaggcgt ccgtctcggg acggagctca ggggaagagc 120
gtgactccag ttgaacgtga tagtcggtgc gttgagagga gacccagtcg ggtgtcgagt 180
cagaaggggc ccggggcccg aggccctggg caggacggcc cgtgccctgc atcacgggcc 240
cagcgtccta gaggcaggac tctggtggag agtgtgaggg tgcctggggc ccctccggag 300
ctggggccgt gcggtgcagg ttgggctctc ggcgcggtgt tggctgtttc tgcgggattt 360
ggaggaattc ttccagtgat gggagtcgcc agtgaccggg caccaggctg tgtctgaaac 420
cagccccaaa atcttcccac tgactctggg gagcagcgag cctgccggat atgtggtcat 480
cgcctgcctg gtccgggact tcttcccgtc agagc 515
<210> 11
<211> 359
<212> DNA
<213> alpha circular transcript (alpha CT)
<400> 11
actccagctc ctatgcagcg gctgggcaga tggacctgcg gtgtggggcc acaaggcccg 60
agaggcctgg gcctctccca gccaccgtgg accctctggc agcttgagca ggtgggtccc 120
agaggctgct caggcctcag ctcctgcaca gccaggccac accggggcct cctgggctgg 180
aagcatggaa ggaaggcagg taccaaaaca aggaggagga gaaggaggaa ggaggggccc 240
tctagccccg aggaccgagg gcaggatgaa cccagaacat ccaggacttc ccgtccgtcc 300
tgagaggcgg caagtacttg gcctcctccc gggtgctcct accctctgtg agcatcccc 359
Claims (6)
1. The pig IgA class converted transcript alpha short sequence PST alpha-1 has the nucleotide sequence of SEQ ID No. 9.
2. The pig IgA class converted transcript alpha long sequence PST alpha-2 has the nucleotide sequence of SEQ ID No. 10.
3. Use of the porcine IgA class converted transcript PST α of claim 1 or 2 for the preparation of a reagent for the detection of mucosal immunity in pigs.
4. Primers SEQ ID No.3 and SEQ ID No.4 for pig IgA class switch recombination detection.
5. Application of primers SEQ ID No.3 and SEQ ID No.4 in preparation of reagents for detecting porcine mucosal immunity.
6. The pig IgA class converting and recombining detection method features that RNA extracted from lymph tissue sample of pig is reverse transcribed, the obtained cDNA is used as template to be detected, primers SEQ ID No.3 and SEQ ID No.4 are used to amplify, and IgA to be detected in the pig is determined based on the specific band in the nucleic acid electrophoresis chart and the DNA molecular weight standard+B cell class switch recombination events.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110206756.1A CN112961863B (en) | 2019-06-04 | 2019-06-04 | Porcine IgA class-switched transcript alpha long and short sequences |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110206756.1A CN112961863B (en) | 2019-06-04 | 2019-06-04 | Porcine IgA class-switched transcript alpha long and short sequences |
CN201910482822.0A CN110128524B (en) | 2019-06-04 | 2019-06-04 | Pig IgA+B cell class conversion marker sequence and detection method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910482822.0A Division CN110128524B (en) | 2019-06-04 | 2019-06-04 | Pig IgA+B cell class conversion marker sequence and detection method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112961863A true CN112961863A (en) | 2021-06-15 |
CN112961863B CN112961863B (en) | 2023-03-10 |
Family
ID=67580270
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110206756.1A Active CN112961863B (en) | 2019-06-04 | 2019-06-04 | Porcine IgA class-switched transcript alpha long and short sequences |
CN201910482822.0A Active CN110128524B (en) | 2019-06-04 | 2019-06-04 | Pig IgA+B cell class conversion marker sequence and detection method |
CN202110206755.7A Active CN112852826B (en) | 2019-06-04 | 2019-06-04 | Pig alpha circular transcript alpha CT gene and application |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910482822.0A Active CN110128524B (en) | 2019-06-04 | 2019-06-04 | Pig IgA+B cell class conversion marker sequence and detection method |
CN202110206755.7A Active CN112852826B (en) | 2019-06-04 | 2019-06-04 | Pig alpha circular transcript alpha CT gene and application |
Country Status (1)
Country | Link |
---|---|
CN (3) | CN112961863B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101389214A (en) * | 2004-10-22 | 2009-03-18 | 雷维维科公司 | Ungulates with genetically modified immune systems |
CN104755493A (en) * | 2012-08-03 | 2015-07-01 | Sab有限责任公司 | Complex chromosome engineering for production of human antibodies in transgenic animals |
CN106794263A (en) * | 2014-10-01 | 2017-05-31 | 宾夕法尼亚大学理事会 | The vaccine of the IL-21 with antigen and as adjuvant |
AU2016322044A1 (en) * | 2015-09-14 | 2018-03-15 | Appux Limited | Running applications on a computing device |
CN108866243A (en) * | 2018-08-31 | 2018-11-23 | 中国农业科学院兰州兽医研究所 | A kind of pig enteric coronavirus virus-4 weight fluorescent quantificationally PCR detecting kit |
CN112409486A (en) * | 2020-11-26 | 2021-02-26 | 杭州百凌生物科技有限公司 | anti-CD 40 antibody and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2501422C (en) * | 2004-04-29 | 2014-08-12 | University Of Rochester | Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease |
CN105506182B (en) * | 2016-01-12 | 2018-10-30 | 中国农业科学院兰州兽医研究所 | A kind of pig virus diarrhoea virus 5 weight RT-PCR detection kit |
CN108101970B (en) * | 2017-12-14 | 2021-02-26 | 江苏省农业科学院 | Cry1Ab toxin mimic antigen based on anti-idiotype nano-antibody and application thereof |
CN108101967B (en) * | 2017-12-27 | 2021-03-02 | 江苏省农业科学院 | I-group serum 4 type avian adenovirus genetic engineering subunit vaccine, preparation method and application thereof |
CN108676078B (en) * | 2018-05-23 | 2021-04-20 | 江苏省农业科学院 | Use of antigens causing the antibody-dependent potentiation of tembusu virus |
-
2019
- 2019-06-04 CN CN202110206756.1A patent/CN112961863B/en active Active
- 2019-06-04 CN CN201910482822.0A patent/CN110128524B/en active Active
- 2019-06-04 CN CN202110206755.7A patent/CN112852826B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101389214A (en) * | 2004-10-22 | 2009-03-18 | 雷维维科公司 | Ungulates with genetically modified immune systems |
CN104755493A (en) * | 2012-08-03 | 2015-07-01 | Sab有限责任公司 | Complex chromosome engineering for production of human antibodies in transgenic animals |
CN106794263A (en) * | 2014-10-01 | 2017-05-31 | 宾夕法尼亚大学理事会 | The vaccine of the IL-21 with antigen and as adjuvant |
AU2016322044A1 (en) * | 2015-09-14 | 2018-03-15 | Appux Limited | Running applications on a computing device |
CN108866243A (en) * | 2018-08-31 | 2018-11-23 | 中国农业科学院兰州兽医研究所 | A kind of pig enteric coronavirus virus-4 weight fluorescent quantificationally PCR detecting kit |
CN112409486A (en) * | 2020-11-26 | 2021-02-26 | 杭州百凌生物科技有限公司 | anti-CD 40 antibody and application thereof |
Non-Patent Citations (9)
Also Published As
Publication number | Publication date |
---|---|
CN112852826A (en) | 2021-05-28 |
CN112961863B (en) | 2023-03-10 |
CN110128524B (en) | 2021-05-07 |
CN110128524A (en) | 2019-08-16 |
CN112852826B (en) | 2023-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107586832B (en) | Compositions and methods for measuring and calibrating amplification bias in multiplex PCR reactions | |
US11339427B2 (en) | Method for target specific RNA transcription of DNA sequences | |
CN115044710B (en) | Primer group and kit for detecting pangolin beta coronavirus and application of primer group and kit | |
JP2023153732A (en) | Method for target specific rna transcription of dna sequences | |
CN110128524B (en) | Pig IgA+B cell class conversion marker sequence and detection method | |
CN109415768B (en) | Variable region sequence library construction method, sequencing method and kit thereof | |
CN109971843B (en) | Sequencing method of single cell transcriptome | |
Le et al. | Development of a simultaneous high resolution typing method for three SLA class II genes, SLA-DQA, SLA-DQB1, and SLA-DRB1 and the analysis of SLA class II haplotypes | |
CN112458208B (en) | Kit and method for detecting bovine sarcoidosis virus | |
CN113528613A (en) | Experimental method for detecting bacterial genes based on multienzyme constant-temperature nucleic acid rapid amplification technology | |
CN116656730B (en) | Recombinant canary pox virus expressing rabies virus G, M protein and construction method thereof | |
CN112795699A (en) | Universal primer, probe and detection method for detecting different subtypes of HIV-1 virus by RT-RAA fluorescence method | |
CN103397028B (en) | Semi-random primer based on PCR walking technology, and kit thereof | |
CN108707653B (en) | Kit for constructing variable region sequence library and sequencing method of variable region sequence | |
CN111850016A (en) | Immune repertoire standard substance sequence and design method and application thereof | |
KR101557844B1 (en) | Primer set for loop-mediated isothermal amplification reaction for detecting iridovirus, Primer composition having the same, and Detecting method for iridovirus using the same | |
CN103397029B (en) | PCR walking method, and primer and kit thereof | |
CN111850165B (en) | RT-PCR detection method for swine fever virus | |
CN109306373B (en) | Joint, primer group and kit for detecting human genome maturation tRNA (transfer ribonucleic acid) spectrum | |
CN110184326B (en) | TPP riboswitch sequence primer and intestinal flora classification method | |
CN110760601A (en) | Primer group and kit for simultaneously detecting Brucella, Chlamydia abortus and Clostridium perfringens and application of primer group and kit | |
US20230227816A1 (en) | Methods and compositions for selective pcr and cloning of antibody sequences | |
Qu et al. | Rapid and sensitive diagnosis of porcine parvovirus by loop-mediated isothermal amplification (LAMP) method | |
Tatliesme et al. | Development of a Molecular Diagnostic Kit for the Sars-Cov-2 Eris Variant. | |
RU2807806C1 (en) | pGEM-TCRAC-sjTREC-sjKREC RECOMBINANT PLASMID DNA CONTAINING NUCLEOTIDE SEQUENCES OF THE T-LYMPHOCYTE Α-RECEPTOR GENE LOCUS AND SIGNAL FRAGMENTS OF THE T- AND B-CELL RECEPTOR EXCISION RINGS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |